Breast Cancer: Kat's Patient Story

Patient Info: Kat

Nine months after diagnosis, she had completed radiation treatment and was looking ahead to recovery and hair regrowth.

Dana-FarberRead more →

Stage III Breast Cancer: Melissa's Patient Story

Patient Info: Melissa Angiolillo, Female, Under 40 | Stage III

Completed double mastectomy, 8 rounds of chemotherapy and 25 radiation treatments over the prior 8 months.

Dana-FarberRead more →

HER2-Positive Inflammatory Breast Cancer: Trish's Patient Story

Patient Info: Trish Vickery, female, 50s

Biomarkers: HER2-positive

At 58, Trish was living an active life after treatment, including working, traveling, exercising, and rowing.

Dana-FarberRead more →

Breast Cancer: Marianne's Survivor Story

Patient Info: Marianne Gongos, Female, 60s

Marianne had been breast cancer-free since June 13, 2013. Her separate chronic myeloid leukemia was also in remission after she restarted its medication.

Cleveland ClinicRead more →

Metastatic Breast Cancer and an Atypical Femoral Fracture During Ibandronate Treatment

Patient Info: Anonymized, female, 50s

She was living with bone-metastatic breast cancer when a suspected new femoral metastasis was instead recognized as an atypical femoral fracture during long-term ibandronate treatment.

PubMed CentralRead more →

Stage IV HER2-Positive Breast Cancer: Sarah's Patient Story

Patient Info: Sarah, Female, Under 40 | Stage IV

Biomarkers: HER2-positive; BRCA and other known hereditary breast cancer genes not identified in family history discussion

As of January 2017, Sarah had been living for almost 3 years with recurrent Stage IV HER2-positive breast cancer and was receiving Kadcyla every 3 weeks.

YouTube — Oncology AssociatesRead more →

Stage III Breast Cancer: Elizabeth's Survivor Story

Patient Info: Elizabeth, 40s | Stage III

Biomarkers: Cancer described as highly hormone-dependent.

Elizabeth said she was in remission and no longer required treatment after lumpectomy, chemotherapy, radiation, and an aromatase-inhibitor clinical trial.

Our Cancer StoriesRead more →

Stage IV Breast Cancer: Debora's Patient Story

Patient Info: Debora, Female, 60s | Stage IV

Debora was living with metastatic breast cancer after Stage III disease treated with surgery, chemotherapy, radiation therapy, and targeted therapy; four years after surgery, she was told the cancer had metastasized and was on targeted therapy.

Our Cancer StoriesRead more →

Stage II Breast Cancer: Tasha's Patient Story

Patient Info: Tasha | Stage II

She completed surgery and radiation and is doing well as a survivor while continuing tamoxifen.

Our Cancer StoriesRead more →

Stage II Breast Cancer: Natalia's Survivor Story

Patient Info: Natalia | Stage II

Natalia was declared cancer-free on February 21, 2024, and continued regular follow-up while taking letrozole.

Our Cancer StoriesRead more →

Stage III Inflammatory Breast Cancer Diagnosed After Severe Breast Pain and Swelling Following Mammography

Patient Info: Anonymized, female, 60s | Stage IV

Biomarkers: ER negative, PR negative, HER2 highly positive

After later metastatic disease was found, she chose no further active treatment and died of progressive disease in 2012.

PubMed CentralRead more →

Breast Cancer: Stephanie's Survivor Story

Patient Info: Stephanie Spiesz, Female, 50s

As of June 2016, Stephanie was fully recovered and cancer-free after breast cancer diagnosed in November 2013 and treated with double mastectomy, chemotherapy and radiation.

Cleveland ClinicRead more →

Stage I Breast Cancer: Shirley's Survivor Story

Patient Info: Shirley | Stage I

Shirley says she completed treatment and is now in remission after Stage I breast cancer.

Our Cancer StoriesRead more →

Stage II Invasive Ductal Carcinoma: Sarah's Patient Story

Patient Info: Sarah Cawley, Female, Under 40 | Stage II

As of August 2015, Sarah was still receiving treatment for Stage II invasive ductal carcinoma after modified radical mastectomy, 6 chemotherapy cycles, 25 radiation treatments and clinical trial participation.

Cleveland ClinicRead more →

Synchronous Stage IA breast cancer and Stage IIA lung adenocarcinoma: disease-free after surgery and adjuvant therapy

Patient Info: Anonymized, Female, 60s | Stage I

Biomarkers: Breast tumor: ER/PR positive, HER2 negative. Lung tumor: KRAS/EGFR wild type, ALK rearrangement not detected.

As of April 2014, more than 2 years of follow-up showed no recurrent disease after treatment of synchronous Stage IA breast cancer and Stage IIA lung adenocarcinoma.

PubMed CentralRead more →

Stage IV ER/PR-positive mucinous breast cancer: long-term no evidence of disease after surgery, AFTV, radiation, CEF, and endocrine therapy

Patient Info: Anonymized, Female, 50s | Stage IV

Biomarkers: ER-positive; PR-positive; delayed-type hypersensitivity to AFTV became pseudo-positive after vaccination and remained pseudo-positive 5.4 years later

Metastatic Site: Th7 vertebra

More than 6 years after primary surgery, she remained well with no evidence of vertebral metastasis activity, new metastasis, or local recurrence.

PubMed CentralRead more →

Metastatic lobular breast cancer to gynecologic sites: disease-free after surgery and chemotherapy

Patient Info: Anonymized, Female, 50s | Stage IV

Biomarkers: ER-positive; PR-negative; HER2/C-Erb-B2-negative

Metastatic Site: vagina, uterus, ovaries

After treatment of vaginal, uterine, and ovarian metastases from lobular breast cancer, she was free from disease 12 months after completion surgery.

PubMed CentralRead more →

Hormone-positive breast cancer with axillary recurrence responding to hyperthermia, radiation, and chemotherapy

Patient Info: Anonymized, Female, 60s

Biomarkers: ER-positive; PR-positive; HER2-negative

The left axillary recurrence enlarged during weekly paclitaxel and radiotherapy, then became nearly flat and was assessed as a complete response 8 weeks after adding hyperthermia.

PubMed CentralRead more →

Metastatic lobular breast cancer to bladder trigone: partial response to tamoxifen

Patient Info: Anonymized, Female, 60s | Stage IV

Biomarkers: progesterone receptor-positive; genetic testing including BRCA1 negative

Metastatic Site: bladder trigone

As of January 2012, urge incontinence had resolved and PET showed decreased activity in the breast and bladder trigone lesions nearly 10 months after starting tamoxifen, consistent with clinical and partial radiologic remission.

PubMed CentralRead more →

Stage III Triple-Negative Breast Cancer: Bridgette's Survivor Story

Patient Info: Bridgette, Female, 60s | Stage III

Biomarkers: Triple-negative breast cancer

Bridgette completed treatment and described herself as being in remission and free of cancer. Fear of recurrence continued to affect her survivorship.

Our Cancer StoriesRead more →

Right breast ductal carcinoma with unusual sentinel-node drainage treated with lumpectomy and adjuvant therapy

Patient Info: Anonymized, Female, 40s

After lumpectomy, negative sentinel lymph node evaluation across 3 drainage territories, chemotherapy, radiotherapy, and hormone therapy, she remained free of disease 2 years and 6 months after surgery.

PubMed CentralRead more →

Lobular breast cancer with extraocular muscle and lung metastases: ocular improvement after radiotherapy and tamoxifen

Patient Info: Anonymized, Female, 60s | Stage IV

Biomarkers: Original breast cancer: ER-negative; PR-negative. Extraocular muscle metastasis/recurrent disease: ER strongly positive; PR strongly positive.

Metastatic Site: bilateral extraocular muscles, right upper lobe lung,…

At 18 months after presentation with extraocular muscle metastases, PET showed no abnormality, diplopia had resolved, and ocular motility had markedly improved, with mild bilateral ptosis remaining.

PubMed CentralRead more →

Triple-negative glycogen-rich clear cell carcinoma of the breast: chemotherapy, mastectomy, and radiation

Patient Info: Anonymized, Female, 50s | Stage III

Biomarkers: Triple-negative breast cancer with glycogen-rich clear cell features; pathology stains supported breast carcinoma.

Asymptomatic and disease-free 14 months after surgery, additional chemotherapy, and 50 Gy radiotherapy for T4N0M0 triple-negative glycogen-rich clear cell breast carcinoma.

PubMed CentralRead more →

ER-positive breast cancer recurrence after DCIS: chemotherapy, nodal surgery, radiation, and endocrine therapy

Patient Info: Anonymized, Female, 40s

Biomarkers: Recurrent invasive breast cancer: ER-positive; HER2/neu-negative. PR not reported.

Disease-free for 33 months after treatment of ER-positive, HER2-negative invasive breast cancer recurring in the mastectomy skin flap with positive axillary sentinel nodes.

PubMed CentralRead more →